PROMBot-HSM-AF: protocol for a feasibility study of a chatbot-based platform to collect patient-reported outcomes after atrial fibrillation ablation - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Feasibility Study Protocol for PROMBot-HSM-AF: A Chatbot-Driven Approach to Gather Patient-Reported Outcomes Following Atrial Fibrillation Ablation

  • By

  • Sérgio Laranjo

  • Pedro Silva Cunha

  • Federico Guede-Fernández

  • Eduarda Oliosi

  • Rita Contins

  • Pedro Dias

  • Catarina Silva

  • Ana Clara Félix

  • Mário Martins Oliveira

  • Ana Rita Londral

  • September 2, 2026

Share

  • 1

    Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 2%-4% of the global population.

  • 2

    Catheter ablation is increasingly used as a first-line treatment for AF, but 15%-20% of patients require reassessment within the first month.

  • 3

    The PROMBot-HSM-AF study will assess the feasibility and acceptability of a chatbot for post-ablation patient-reported outcomes.

  • 4

    The study will involve 76 patients randomized to receive either chatbot-supported follow-up or standard care.

  • 5

    Patient engagement and usability will be evaluated using various measures, including the System Usability Scale and semi-structured interviews.

Original Source(s)

PROMBot-HSM-AF: protocol for a feasibility study of a chatbot-based platform to collect patient-reported outcomes after atrial fibrillation ablation

  • by Sérgio Laranjo, Pedro Silva Cunha, Federico Guede-Fernández, Eduarda Oliosi, Rita Contins, Pedro Dias, Catarina Silva, Ana Clara Félix, Mário Martins Oliveira, Ana Rita Londral

  • September 2, 2026

Related Content

Toward Precision Cardio-Oncology in Breast Radiotherapy

Sodium Thiosulfate for Refractory Metabolic Alkalosis From Diuretic Therapy: A Case Series of Six Patients

  • September 1, 2026

Sensitivity and specificity of speckle tracking echocardiography for coronary artery disease: a systematic review and meta-analysis